Glycemic Effects and Safety of L-Glutamine Supplementation with or without Sitagliptin in Type 2 Diabetes Patients—A Randomized Study

BACKGROUND AND AIMS: L-glutamine is an efficacious glucagon-like peptide (GLP)-1 secretagogue in vitro. When administered with a meal, glutamine increases GLP-1 and insulin excursions and reduces postprandial glycaemia in type 2 diabetes patients. The aim of the study was to assess the efficacy and...

Descripción completa

Detalles Bibliográficos
Autores principales: Samocha-Bonet, Dorit, Chisholm, Donald J., Gribble, Fiona M., Coster, Adelle C. F., Carpenter, Kevin H., Jones, Graham R. D., Holst, Jens J., Greenfield, Jerry R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4239068/
https://www.ncbi.nlm.nih.gov/pubmed/25412338
http://dx.doi.org/10.1371/journal.pone.0113366

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4239068/
https://www.ncbi.nlm.nih.gov/pubmed/25412338
http://dx.doi.org/10.1371/journal.pone.0113366

Ejemplares similares